Viewing Study NCT02545504


Ignite Creation Date: 2025-12-24 @ 9:17 PM
Ignite Modification Date: 2026-01-06 @ 10:24 PM
Study NCT ID: NCT02545504
Status: COMPLETED
Last Update Posted: 2020-05-26
First Post: 2015-09-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Sponsor: Gilead Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gastroesophageal junction (GEJ) View
None Stomach cancer View